Financials
- Market Capitalization 786.68 M
- Employee 196
- Founded 2013
- CEO N/A
- Website www.4dmoleculartherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00QG40R88
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-3.1
Relación precio/flujo de caja
5.1
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2605 | NVCT Nuvectis Pharma, Inc. - Common Stock | 25.19 USD | +0.76% | +8.62% | +26.27% | +273.74% | 820.73 M USD | ||
| 2617 | DBVT DBV Technologies S.A. - American Depositary Shares | 13.64 USD | -5.34% | -6.38% | -0.58% | +43.58% | 807.66 M USD | ||
| 2643 | AURA Aura Biosciences, Inc. - Common Stock | 7.50 USD | -2.60% | -5.18% | +6.69% | +15.74% | 777.79 M USD | ||
| 2662 | NGNE Neurogene Inc. - Common Stock | 37.86 USD | -1.43% | -0.81% | +16.17% | +28.69% | 757.63 M USD |